A three-pronged approach was followed for deducing the intravenous infusion pump market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for intravenous infusion pump market to gather the most reliable and current information possible.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of intravenous infusion pump market data depending on the type of information we’re trying to uncover in our research.
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
This step also entails the finalization of the report scope and data representation pattern.
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
The intravenous infusion pump market was categorized into three segments, namely product (Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps), disease indication (Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).
The intravenous infusion pump market was segmented into product, disease indication, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Demand estimation of each product across countries/regions summed up to from the total market.
Variable analysis for demand forecast.
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
Primary interviews for data revalidation and insight collection.
Used extensively for new product forecasting or analyzing penetration levels.
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
Primary interviews and vendor-based primary research for variable impact analysis.
The intravenous infusion pump market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into thirty-two countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Netherlands; Belgium; Switzerland; Russia; Sweden; China; India; Japan; Australia; South Korea; Malaysia; Singapore; Philippines; Thailand; New Zealand; Mexico; Brazil; Argentina; Colombia; Chile; South Africa; Saudi Arabia; UAE; Israel; Egypt.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
The intravenous infusion pump market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
Baxter - Baxter is a U.S.-based company that primarily develops and markets advanced products to treat hemophilia, kidney diseases, immune disorders, and other chronic & acute medical disorders. It also has intravenous products, such as Spectrum IQ Infusion Systems, for the delivery of fluids and drugs to patients. The company specializes in inhalational anesthetics, contract manufacturing services, and irreversible kidney failure. It achieved global sales of USD 11.1 billion in 2018.
B. Braun Melsungen AG - B. Braun SE is a medical and pharmaceutical device company that provides various healthcare products and services for diabetes care, extracorporeal blood treatment, neurosurgery, nutrition, ostomy surgery, etc. The company operates through six divisions: B. Braun Avitum, Hospital Care, Aesculap, Outpatient Market, Trans Care, and B. Braun Sterilog. It has more than 260 subsidiaries and manufacturing sites in the U.S., Switzerland, Vietnam, Brazil, and Malaysia. In addition, the company has operations in nearly 60 countries. It operates as a subsidiary of B. Braun Holding GmbH & Co. KG.
Medtronic - Medtronic is a global healthcare products company that manufactures medical devices. This company has operations in various healthcare verticals such as patient monitoring, renal care, and pulse oximetry. It also manufactures advanced energybased surgical devices, gastrointestinal devices, brain monitoring equipment, and mechanical ventilation. The company has acquired six companies from 2019 to 2020.
Fresenius Kabi AG - Fresenius Kabi AG is a healthcare company operating in therapeutic areas such as anesthesia, biosimilar, oncology, renal inefficiency, and liver inefficiency. It also manufactures infusion pumps for fluid management, critical illness, and blood volume substitution. The company has four divisions: Fresenius Healthcare, Fresenius Helios, Fresenius Kabi, and Fresenius Vamid.
Smiths Medical - Smiths Medical is a world leader in advanced technologies. The company develops and manufactures medical devices and specializes in providing services in various areas, including pain management, cardiology, respiratory care, home care, & emergency medicines. The company also delivers intelligent infusion technology products for critical care procedures. Moreover, the company offers veterinary devices, OEM services, medical device solutions for preclinical & clinical research, and monitoring & respiratory equipment. It is a subsidiary of Smiths Group plc. The company has manufacturing facilities mainly in the U.S., the UK, Mexico, and Italy.
Micrel Medical Devices SA - Micrel Medical Devices SA is a privately-owned company with operations in more than 30 countries. The company has expertise in designing, manufacturing, and marketing a variety of infusion pump devices, ranging from ambulatory volumetric & syringe infusion pumps and administration sets to remote patient infusion control & monitoring systems. The company has a partnership with Alaris—a U.S.-based firm—for its global distribution. The company manufactures medical devices that address the therapeutic areas of immunotherapy, chemotherapy, and antibiotics.
Boston Scientific Corporation - Boston Scientific Corporation, currently doing business as Boston Scientific, deals with medical specialty products such as interventional radiology, cardiology, neuromodulators, vascular surgery products, and diagnostic monitoring products. The company is present in more than 130 countries. In June 2012, the company acquired Cameron Health, which is known for its minimally invasive implantable cardioverter defibrillators.
CareFusion Corporation - CareFusion Corporation was acquired by Becton Dickinson in 2015 and is among the leading companies in the field of medical delivery and diagnostics. The company has capabilities in biopsy, biosciences, cervical cancer screening, diabetes care, and drug delivery systems. It also offers healthcare technologies that aid in respiratory & ventilation products, preanalytical systems, biosciences, Pyxis automated dispensing & patient identification systems, and Alaris IV sets & infusion pumps. The company also specializes in infusion therapy.
Mindray - Founded in 1991, Mindray is one of the leading global providers of medical devices and solutions. Firmly committed to our mission of “advance medical technologies to make healthcare more accessible”, we are dedicated to innovation in the fields of Patient Monitoring & Life Support, In-Vitro Diagnostics, and Medical Imaging System. Mindray possesses a sound global R&D, marketing and service network. Inspired by the needs of our customers, we adopt advanced technologies and transform them into accessible innovation, bringing healthcare within reach. While improving the quality of care, we help reduce its cost, making it more accessible to a larger part of humanity.
Moog Inc. - Moog is an American-based designer company which is headquartered in Elma, New York. The company is manufacturer of electric, electro-hydraulic and hydraulic motion, controls and systems for applications in aerospace, defense, industrial and medical devices. The company operates under four segments: aircraft controls, space and defense controls, industrial controls, and components. Moog has sales, engineering, and manufacturing facilities in twenty-six countries.
Supply Side Estimates
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
Segment revenue determination via variable analysis and penetration modeling.
Competitive benchmarking to identify market leaders and their collective revenue shares.
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
Identifying parent markets and ancillary markets
Segment penetration analysis to obtain pertinent
Heuristic forecasting with the help of subject matter experts
Forecasting via variable analysis
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
Inflation has not been accounted for to estimate and forecast the market.
Numbers may not add up due to rounding off.
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
Latin America includes Central American countries and the South American continent
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
GET A FREE SAMPLE
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member